Location: Online

Cleaning validation is a key part of pharmaceutical, biopharmaceutical, and medical device manufacturing. One of the critical steps in performing a successful cleaning validation is establishing the limits of residue that can remain on the surface being cleaned. Robust cleaning validation and setting health-based exposure limits have been identified as effective ways to prevent cross-contamination. As a result, new sets of requirements around these topics were added to the EU GMP updates. 

What will we be covering:  
During this webinar, we will shed light on the European changes and how these changes are now linked to each other and the impact they have on cleaning validation programs. We will explore approaches to establishing limits for cleaning validation using the recent PDE, ADE models and the traditional approach. We will give the user a robust approach to developing residue limits for a variety of dosage forms and products. This webinar will provide different case studies and answer FAQs by pharmaceutical manufacturers. Finally, we will share the common challenges met by the manufacturer during cleaning validation and how to address them.

Who will benefit: Manufacturing, Validation, Quality personnel 

Date:  February 1

Time: 15:00 – 16:00 CET – Central European Time

Register now